0001104659-19-062958.txt : 20191113
0001104659-19-062958.hdr.sgml : 20191113
20191113090149
ACCESSION NUMBER: 0001104659-19-062958
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190930
FILED AS OF DATE: 20191113
DATE AS OF CHANGE: 20191113
EFFECTIVENESS DATE: 20191113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management II, LLC
CENTRAL INDEX KEY: 0001594912
IRS NUMBER: 464028844
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16497
FILM NUMBER: 191211843
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001594912
XXXXXXXX
09-30-2019
09-30-2019
false
Foresite Capital Management II, LLC
600 Montgomery Street
Suite 4500
San Francisco
CA
94111
13F HOLDINGS REPORT
028-16497
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
11-13-2019
0
7
473022
INFORMATION TABLE
2
infotable.xml
10x Genomics, Inc.
CLASS A COMMON
88025U109
344598
6837253
SH
SOLE
6837253
0
0
Acceleron Pharma Inc.
COM
00434H108
7452
188602
SH
SOLE
188602
0
0
Aerie Pharmaceuticals, Inc.
COM
00771V108
32150
1672714
SH
SOLE
1672714
0
0
Aimmune Therapeutics, Inc.
COM
00900T107
54559
2605499
SH
SOLE
2605499
0
0
Alder BioPharmaceuticals, Inc.
COM
014339105
2769
146800
SH
SOLE
146800
0
0
Epizyme, Inc.
COM
29428V104
15353
1488444
SH
SOLE
1488444
0
0
Insmed Incorporated
COM
457669307
16141
915016
SH
SOLE
915016
0
0